646
Participants
Start Date
February 13, 2023
Primary Completion Date
July 28, 2023
Study Completion Date
July 28, 2023
Dihydroartemisinin-Piperaquine
Treatment will be with DP (females less than 10 years old and all males) or chloroquine alone (females 10 years old or older).
Chloroquine
Treatment of females 10 years old and older in Arm 1 and treatment of all participants in Arm 2.
Sulfadoxine pyrimethamine
Treatment will be with SP and chloroquine (females less than 10 years old and all males) or chloroquine alone (females 10 years old or older).
Kamuzu University of Health Sciences, Blantyre
Kamuzu University of Health Sciences
OTHER
Doris Duke Charitable Foundation
OTHER
University of Maryland, Baltimore
OTHER